June 1, 2026: Eli Lilly Files to Exclude Testimony and Dismiss Lawsuits The maker of Zepbound, Eli Lilly, has asked for lawsuits in the GLP-1 MDL to be dismissed

semaglutide should be discontinued at least two months before a planned pregnancy During treatment , patients should: Attend all scheduled follow-up appointments to monitor both metabolic parameters and general wellbeing Keep a symptom diary noting any mood changes, particularly in the first three months of treatment Maintain open communication with healthcare providers about any concerns, however minor they may seem Continue existing mental health treatments unless specifically advised otherwise by a psychiatrist Adopt healthy lifestyle measures including regular physical activity, adequate sleep, and balanced nutrition, which support both metabolic and mental health Be aware that hypoglycaemia risk increases when GLP-1 agonists are used with insulin or sulfonylureas, and dose adjustments of these medications may be needed Common adverse effects of GLP-1 agonists include nausea, vomiting, diarrhoea, and constipation, which typically improve over time

-Scott 2 June 2009 Ive used MT-2 and I think it was from China
One possible explanation is that they act on parts of the brain that control reward and satisfaction
Semaglutide in four formats (injections, lozenges, drops, liposomal tablets) and tirzepatide in two (injections, drops), plus branded Wegovy and Zepbound